Latest Novocure News & Updates

See the latest news and media coverage for Novocure. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Novocure

Global oncology company

novocure.com
Headquarters
Baar, Switzerland
Founded year
2000
Company type
Public company
Number of employees
1,500–5,000

Last updated

Latest news about Novocure

In short: Novocure received FDA approval for Optune Pax in pancreatic cancer and reported record Q2 2026 revenues of $184 million.

Company announcements

Novocure

Novocure receives CE Mark for pancreatic cancer treatment

The CE Mark is based on Phase 3 PANOVA-3 trial showing improved overall survival and delayed pain progression.

Unlock all announcements with a

Media coverage

onvista

NovoCure Stock

Real-time stock price of NovoCure with live chart & price development News & analyses Place it for free in your onvista demo portfolio and observe it long-term!

Yahoo Finance

NovoCure (NVCR) Upgraded to Buy: What Does It Mean for the Stock?

NovoCure (NVCR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the...

Unlock all articles with a

Never miss news about Novocure

Track Novocure and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.